Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | benzathine benzylpenicillin | 25137901 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | benzathine benzylpenicillin | 25137901 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzathine benzylpenicillin | 25137901 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | benzathine benzylpenicillin | 25137901 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | benzathine benzylpenicillin | 25137901 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cefuroxime | 68094 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | cefuroxime | 68094 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | cefuroxime | 68094 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | cefuroxime | 68094 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | cefuroxime | 68094 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | finasteride | 57363 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | finasteride | 57363 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | finasteride | 57363 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | finasteride | 57363 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | finasteride | 57363 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | finasteride | 57363 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | finasteride | 57363 | drug-path |